GERM

Amplify Treatments, Testing and Advancements ETF
GERM

Overview Fund Activity
Delisted

GERM was delisted on the 5th of September, 2024.

Back to rankings

25 hedge funds and large institutions have $5.14M invested in Amplify Treatments, Testing and Advancements ETF in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 5 closing their positions.

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$788K
2
Citadel Advisors
2
Citadel Advisors
Florida
$632K
3
LPL Financial
3
LPL Financial
California
$1.38M
4
Commonwealth Equity Services
4
Commonwealth Equity Services
Massachusetts
$388K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$6K

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$629K
2
UBS Group
2
UBS Group
Switzerland
$11K
3
APA
3
American Portfolios Advisors
New York
$236K
4
Osaic Holdings
4
Osaic Holdings
Arizona
$70K
5
CAPTRUST Financial Advisors
5
CAPTRUST Financial Advisors
North Carolina
$274K
Name Holding Trade Value Shares
Change 		Shares
Change %
Koshinski Asset Management
26
Koshinski Asset Management
Illinois
– -$17.2K -629 Closed
Simplex Trading
27
Simplex Trading
Illinois
– -$9K -333 Closed
TFP
28
Tilia Fiduciary Partners
North Carolina
– -$5K -183 Closed
BHWM
29
Beaird Harris Wealth Management
Texas
– -$1K -46 Closed
1
2